“world in motion” – emulsion adjuvants rising to meet the pandemic challenges

HIGHLIGHTS

• who: Derek T. O’Hagan from the (UNIVERSITY) have published the Article: “World in motion” - emulsion adjuvants rising to meet the pandemic challenges, in the Journal: (JOURNAL) of 31/07/2021
• what: This approach has also been adopted by other manufacturers, such as Sanofi for their high-dose vaccine for older adults, with a relative efficacy trial performed post-licensure37, and Novavax, with their matrix-M adjuvanted vaccine38. This study (Influence65) was designed as a relative efficacy trial incorporating Published in partnership with the Sealy Institute for Vaccine Sciences 3 two consecutive influenza seasons and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.